Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 16.1B | 13.5B | 24.7B | 15.7B |
| Cost of revenue | 13.7B | 11.7B | 20.7B | 13.2B |
| Gross profit | 2.4B | 1.9B | 4.0B | 2.5B |
| Operating expense | ||||
| Research & development | 733M | 673M | 899M | 758M |
| Selling general and admin | 638M | 665M | 675M | 602M |
| Other operating expenses | — | — | — | — |
| Operating income | 1.0B | 540M | 2.5B | 1.1B |
| Non operating interest income | ||||
| Income | 171M | 209M | 221M | 183M |
| Expense | 194M | 189M | 260M | 212M |
| Other income expense | — | — | — | — |
| Pretax income | 1.0B | 1.1B | 2.8B | 1.3B |
| Tax provision | 314M | 349M | 420M | 312M |
| Net income | 699M | 745M | 2.4B | 938M |
| Basic EPS | 0.2 | 0.3 | — | 0.3 |
| Diluted EPS | 0.2 | 0.3 | — | 0.3 |
| Basic average shares | 3.1B | 3.1B | — | 3.2B |
| Diluted average shares | 3.1B | 3.2B | — | 3.2B |
| EBITDA | 1.8B | 1.9B | 4.1B | 2.0B |
| Net income from continuing op. | 699M | 745M | 2.4B | 938M |
| Minority interests | 33M | 48M | 17M | 45M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |